P. aeruginosa Infection Increases Morbidity in Experimental Cholesteatomas

被引:21
|
作者
Jung, Jae Y. [1 ]
Lee, Dong H. [3 ]
Wang, Eric W. [1 ]
Nason, Robert [1 ]
Sinnwell, Toni M. [1 ]
Vogel, Joseph P. [3 ]
Chole, Richard A. [1 ,2 ]
机构
[1] Washington Univ, Sch Med, Dept Otolaryngol, St Louis, MO 63131 USA
[2] Washington Univ, Dept Dev Biol, St Louis, MO 63131 USA
[3] Washington Univ, Sch Med, Dept Microbiol, St Louis, MO 63131 USA
来源
LARYNGOSCOPE | 2011年 / 121卷 / 11期
关键词
Cholesteatoma; P; aeruginosa; micro-CT; gerbil; bone resorption; PSEUDOMONAS-AERUGINOSA; OTITIS-MEDIA; MICROBIAL BIOFILMS; PNEUMOCYTE CELLS; ADHERENCE; VIRULENCE; PILIN;
D O I
10.1002/lary.22189
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Objectives: Clinicians have long noted that infected cholesteatomas are more aggressive than uninfected ones without data to support these observations. The purpose of this study is to determine the etiological role of biofilm forming P. aeruginosa (PA) and the virulence factor, type IV pili (TFP), in the pathogenesis of experimental cholesteatomas. Design: We evaluated three different PA strains and one Escherichia coli strain in cholesteatoma progression: PA14, a well-characterized wound isolate, OPPA8, an otopathogenic strain from a human cholesteatoma, OPPA8-NP, an isogenic TFP deletion mutant, and DH5 alpha, an E. coli strain. Methods: Cholesteatomas were induced in gerbils. We inoculated the right ear with bacteria and the left with vehicle. After 6 weeks their cholesteatomas were evaluated by micro-CT scanning. Cholesteatoma size and bone resorption were analyzed digitally. Results: Results demonstrate that PA infection increases cholesteatoma size when compared to uninfected controls: OPPA8 showed an 8.9-fold increase, PA14 a 2.6-fold increase, OPPA8-NP a 1.9-fold increase, while DH5a was not increased over controls. Additionally, infected bullae showed 10 to 50% more cholesteatoma-induced bone resorption. Conclusions: In this model, PA infected cholesteatomas enlarge more rapidly and are more destructive than uninfected controls. OPPA8, the strain from a human cholesteatoma, showed the greatest enlargement and bone destruction. Additionally, we demonstrate that TFP is a virulence factor in this model because the nonpiliated isogenic mutant, OPPA8-NP, was significantly less aggressive than the wild-type OPPA8 indicating that type IV pili may be a virulence factor in this disease.
引用
收藏
页码:2449 / 2454
页数:6
相关论文
共 50 条
  • [31] Fcγ receptor IIA genotype and susceptibility to P. aeruginosa infection in patients with cystic fibrosis
    Virginia De Rose
    Carlo Arduino
    Nazario Cappello
    Rita Piana
    Paola Salmin
    Marco Bardessono
    Manuela Goia
    Rita Padoan
    Elisabetta Bignamini
    Diana Costantini
    Giovanna Pizzamiglio
    Veronica Bennato
    Carla Colombo
    AnnaMaria Giunta
    Alberto Piazza
    European Journal of Human Genetics, 2005, 13 : 96 - 101
  • [32] SPECT Imaging of P. aeruginosa Infection in Mice Using 123I-BMIPP
    Nishiyama, Yuri
    Mizutani, Asuka
    Kobayashi, Masato
    Muranaka, Yuka
    Sato, Kakeru
    Maki, Hideki
    Kawai, Keiichi
    PHARMACEUTICS, 2024, 16 (05)
  • [33] Delayed host mortality and immune response upon infection with P. aeruginosa persister cells
    Hastings, Cody J.
    Keledjian, Maya V.
    Musselman, Laura Palanker
    Marques, Claudia N. H.
    INFECTION AND IMMUNITY, 2023, 91 (10)
  • [34] A chronic lung infection model with P. aeruginosa for evaluation of novel anti-infectives
    Rox, K.
    Greweling-Pils, M. C.
    Haeussler, S.
    Medina, E.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2023, 396 : S23 - S23
  • [35] Evaluation of specific immune response in early P. aeruginosa infection in cystic fibrosis patients
    Dolce, Daniela
    Cariani, Lisa
    Campana, Silvia
    Ravenni, Novella
    Mergni, Gianfranco
    Biffi, Arianna
    Colombo, Carla
    Gagliardini, Rolando
    Cirilli, Natalia
    Manso, Ester
    Padoan, Rita
    Soncini, Elena
    Forte, Fabio Rocco
    D'Aprile, Angelica
    Ratclif, Luigi
    Amboni, Maura
    Casciaro, Rosaria
    Minicucci, Laura
    Borio, Tatiana
    Cosimi, Angelo
    Vieni, Giuseppe
    Zinnarello, Clara
    Fiscarelli, Ersilia
    Collura, Mirella
    Pensabene, Tiziana
    Braggion, Cesare
    Doering, Gerd
    Taccetti, Giovanni
    JOURNAL OF CYSTIC FIBROSIS, 2014, 13 (01) : 116 - 117
  • [36] Peripheral immune cells are associated with disease severity and chronic P. aeruginosa infection in Bronchiectasis
    Barco, Nuria Mendoza
    Solarat, Belen
    Perea, Lidia
    Robres, Lucas
    Casas, Sandra
    Marrades, Pau
    Amaro, Rosanel
    Soler, Nestor
    Martinez-Olondris, Pilar
    Villanueva, Miriam
    Marco, Francesc
    Suarez-Cuartin, Guillermo
    Agusti, Alvar
    Shoemark, Amelia
    Chalmers, James
    Faner, Rosa
    Sibila, Oriol
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [37] Antimicrobial efficacy and toxicity of novel CAMPs against P. aeruginosa infection in a murine skin wound infection model
    Ming Yang
    Chunye Zhang
    Sarah A. Hansen
    William J. Mitchell
    Michael Z. Zhang
    Shuping Zhang
    BMC Microbiology, 19
  • [38] Antimicrobial efficacy and toxicity of novel CAMPs against P. aeruginosa infection in a murine skin wound infection model
    Yang, Ming
    Zhang, Chunye
    Hansen, Sarah A.
    Mitchell, William J.
    Zhang, Michael Z.
    Zhang, Shuping
    BMC MICROBIOLOGY, 2019, 19 (01)
  • [39] DNA aptamers targeting P. aeruginosa RNAP
    Timilsina, Hari
    Kompaniiets, Dmytro
    Arya, Satya Prakash
    Postema, Rick Mason
    Jahan, Raunak
    Reynolds, Andrew Michael
    Thennakoon, Siddhartha Kalpa Samadhi
    Liu, Bin
    Tan, Xiaohong
    CHEMICAL COMMUNICATIONS, 2025, 61 (25) : 4848 - 4851
  • [40] On antimicrobial resistance among P. aeruginosa and Enterobacteriaceae
    Tascini, C.
    Tagliaferri, E.
    Menichetti, E.
    MINERVA ANESTESIOLOGICA, 2010, 76 (06) : 466 - 466